Literature DB >> 25270517

Relationship between sniff nasal inspiratory pressure and BODE index in patients with COPD.

Leila Donária1, Rafael Mesquita, Larissa Martinez, Luciana Sípoli, Josiane Marques Felcar, Vanessa Suziane Probst, Nidia Aparecida Hernandes, Fabio Pitta.   

Abstract

PURPOSE: The aims of this study were to investigate the relationship between sniff nasal inspiratory pressure (SNIP) and severity of chronic obstructive pulmonary disease (COPD) as defined by the BODE index, and to investigate the capacity of different SNIP cutoffs to predict a BODE index score ≥5 (i.e., worse disease severity).
METHODS: Thirty-eight subjects with COPD (21 men, 66 ± 8 years, forced expiratory volume in the first second (FEV(1)) 42 ± 16 % predicted) underwent assessments of SNIP, airflow limitation, body mass index (BMI), dyspnea (Medical Research Council scale), and exercise capacity (6-min walking test, 6MWT). The BODE index was calculated, and patients were separated into two groups according to the BODE quartiles (1 and 2, or 3 and 4).
RESULTS: Patients from quartiles 3 and 4 presented lower values of SNIP than patients from quartiles 1 and 2 (73 ± 18 vs 56 ± 21 cmH(2)O, respectively; p = 0.01). There was significant and inverse correlation between SNIP and the BODE index (r = -0.62; p<0.001). A logistic regression model revealed that a SNIP value below 63 cmH(2)O presented higher sensitivity and specificity (70 and 67 %, respectively) for predicting a BODE score equivalent to quartiles 3 or 4.
CONCLUSION: SNIP is moderately and significantly related to COPD severity as assessed by the BODE index. Moreover, the cutoff point of 63 cmH2O showed the best combination of sensitivity and specificity for predicting worse scores in the BODE index.

Entities:  

Mesh:

Year:  2014        PMID: 25270517     DOI: 10.1007/s00408-014-9649-7

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  28 in total

1.  ATS/ERS Statement on respiratory muscle testing.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-08-15       Impact factor: 21.405

2.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

3.  Sniff nasal inspiratory pressure versus IC/TLC ratio as predictors of mortality in COPD.

Authors:  Alastair J Moore; Rosa Suades Soler; Edward J Cetti; S Amanda Sathyapala; Nicholas S Hopkinson; Michael Roughton; John Moxham; Michael I Polkey
Journal:  Respir Med       Date:  2010-09       Impact factor: 3.415

4.  Sex-related differences in COPD in five Latin American cities: the PLATINO study.

Authors:  M V Lopez Varela; M Montes de Oca; R J Halbert; A Muiño; R Perez-Padilla; C Tálamo; J R B Jardim; G Valdivia; J Pertuzé; D Moreno; A M B Menezes
Journal:  Eur Respir J       Date:  2010-04-08       Impact factor: 16.671

5.  Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease.

Authors:  Ciro Casanova; Claudia Cote; Juan P de Torres; Armando Aguirre-Jaime; Jose M Marin; Victor Pinto-Plata; Bartolome R Celli
Journal:  Am J Respir Crit Care Med       Date:  2004-12-10       Impact factor: 21.405

Review 6.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

Review 7.  Predictors of mortality in COPD.

Authors:  Bartolome R Celli
Journal:  Respir Med       Date:  2010-04-22       Impact factor: 3.415

Review 8.  Airflow obstruction and exercise.

Authors:  Christopher B Cooper
Journal:  Respir Med       Date:  2008-12-13       Impact factor: 3.415

9.  Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.

Authors:  Milo A Puhan; Judith Garcia-Aymerich; Martin Frey; Gerben ter Riet; Josep M Antó; Alvar G Agustí; Federico P Gómez; Roberto Rodríguez-Roisín; Karel G M Moons; Alphons G Kessels; Ulrike Held
Journal:  Lancet       Date:  2009-08-29       Impact factor: 79.321

10.  Comparison of daily physical activity between COPD patients from Central Europe and South America.

Authors:  Fábio Pitta; Marie-Kathrin Breyer; Nídia A Hernandes; Denílson Teixeira; Thaís J P Sant'Anna; Andréa D Fontana; Vanessa S Probst; Antonio F Brunetto; Martijn A Spruit; Emiel F M Wouters; Otto C Burghuber; Sylvia Hartl
Journal:  Respir Med       Date:  2008-11-09       Impact factor: 3.415

View more
  7 in total

1.  The Relationship of Partial Pressure of Carbon Dioxide (PaCO2) with Disease Severity Indicators Such as BODE and GOLD in Hospitalized COPD Patients.

Authors:  Xiaodiao Zhang; Xiaqi Miao; Keke Ding; Jianing Wang; Binbin Hu; Xueting Hu; Jiamin Shen; Chunyan Liu; Yage Xu; Xiuxiu Zhao; Lulu Bao; Wei Chen; Beibei Zhang; Yiben Huang
Journal:  Int J Clin Pract       Date:  2022-03-16       Impact factor: 3.149

2.  Associations between bone mineral density and chronic obstructive pulmonary disease.

Authors:  Xiaodiao Zhang; Keke Ding; Xiaqi Miao; Jianing Wang; Binbin Hu; Jiamin Shen; Xueting Hu; Yage Xu; Beibei Yu; Tingting Tu; Aiju Lin; Xianjing Chen; Yiben Huang
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

Review 3.  Pulmonary function testing in COPD: looking beyond the curtain of FEV1.

Authors:  Sotirios Kakavas; Ourania S Kotsiou; Fotis Perlikos; Maria Mermiri; Georgios Mavrovounis; Konstantinos Gourgoulianis; Ioannis Pantazopoulos
Journal:  NPJ Prim Care Respir Med       Date:  2021-05-07       Impact factor: 2.871

4.  The BODE index and inspiratory muscle performance in COPD: Clinical findings and implications.

Authors:  Magno F Formiga; Isabel Vital; Gisel Urdaneta; Kira Balestrini; Lawrence P Cahalin; Michael A Campos
Journal:  SAGE Open Med       Date:  2018-12-12

5.  The Relationship of Lymphocyte to High-Density Lipoprotein Ratio with Pulmonary Function in COPD.

Authors:  Yiben Huang; Bingqian Jiang; Xiaqi Miao; Jiedong Ma; Jianing Wang; Keke Ding; Xianjing Chen; Qiaoming Hu; Fangyi Fu; Tian Zeng; Jingyu Hu; Binbin Hu; Dehao Yang; Xiaodiao Zhang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-12-01

6.  Test of incremental respiratory endurance as home-based, stand-alone therapy in chronic obstructive pulmonary disease: A case report.

Authors:  Filip Dosbaba; Martin Hartman; Ladislav Batalik; Kristian Brat; Marek Plutinsky; Jakub Hnatiak; Magno F Formiga; Lawrence Patrick Cahalin
Journal:  World J Clin Cases       Date:  2022-01-07       Impact factor: 1.337

Review 7.  Brazilian studies on pulmonary function in COPD patients: what are the gaps?

Authors:  Agnaldo José Lopes; Pedro Lopes de Melo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-07-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.